Nanosphere Q3 Revenues Plunge 49 Percent on End of Service Contracts | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere took a 49 percent hit in its third quarter revenues year over year, the company reported after the close of the market on Wednesday.

For the three months ended Sept. 30, the company recorded revenues of $373,437, compared to $729,017 a year ago, short of Wall Street expectations, which had estimated $670,000 in revenues.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.